1-1760748-C-A
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_023018.5(NADK):c.263+1204G>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0134 in 150,548 control chromosomes in the GnomAD database, including 108 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.013 ( 108 hom., cov: 33)
Consequence
NADK
NM_023018.5 intron
NM_023018.5 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.474
Publications
1 publications found
Genes affected
NADK (HGNC:29831): (NAD kinase) NADK catalyzes the transfer of a phosphate group from ATP to NAD to generate NADP, which in its reduced form acts as an electron donor for biosynthetic reactions (Lerner et al., 2001 [PubMed 11594753]).[supplied by OMIM, Mar 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.0951 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| NADK | NM_023018.5 | c.263+1204G>T | intron_variant | Intron 3 of 11 | ENST00000341426.9 | NP_075394.3 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0133 AC: 2005AN: 150428Hom.: 109 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
2005
AN:
150428
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.0134 AC: 2010AN: 150548Hom.: 108 Cov.: 33 AF XY: 0.0149 AC XY: 1095AN XY: 73640 show subpopulations
GnomAD4 genome
AF:
AC:
2010
AN:
150548
Hom.:
Cov.:
33
AF XY:
AC XY:
1095
AN XY:
73640
show subpopulations
African (AFR)
AF:
AC:
87
AN:
40452
American (AMR)
AF:
AC:
1507
AN:
15188
Ashkenazi Jewish (ASJ)
AF:
AC:
15
AN:
3470
East Asian (EAS)
AF:
AC:
0
AN:
5096
South Asian (SAS)
AF:
AC:
4
AN:
4806
European-Finnish (FIN)
AF:
AC:
16
AN:
10596
Middle Eastern (MID)
AF:
AC:
0
AN:
290
European-Non Finnish (NFE)
AF:
AC:
351
AN:
67694
Other (OTH)
AF:
AC:
30
AN:
2094
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
91
181
272
362
453
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
10
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.